Hydrogels to treat lupus, autoimmune disorders

Drug delivered: Immunosuppressant (mycophenolic acid)
Innovation: Precise autoimmune disease targeting
Research organization: Yale University

Yale researchers discovered a new way to target autoimmune diseases such as lupus, multiple sclerosis and Type 1 diabetes: nanogels.

By using a small particle that incorporates hydrogels with the immunosuppressant mycophenolic acid, the researchers were able to distribute the drugs more efficiently to attack aberrant immune cells in the body. Without the precision afforded by the nanogel, the drugs are more likely to attack healthy cells as well.

Thus, with the ability to deliver higher doses safely in animal testing, researchers showed they could extend lupus life expectancy by approximately 8 years.

Hydrogels to treat lupus, autoimmune disorders

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.